🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ray Dalio’s RARE Holdings & Trades

First Buy
Q1 2023
Duration Held
6 Quarters
Largest Add
Q3 2026
+57,052 Shares
Current Position
57,052 Shares
$857,492 Value

Ray Dalio's RARE Position Overview

Ray Dalio (via Bridgewater Associates, Lp) currently holds 57,052 shares of Ultragenyx Pharmaceutical Inc. (RARE) worth $857,492, representing 0.00% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 6 quarters.

Based on 13F filings, Ray Dalio has maintained this position in RARE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 57,052 shares. Largest reduction occurred in Q1 2024, reducing 10,635 shares.

Analysis based on 13F filings available since 2013 Q2

Ray Dalio's Ultragenyx Pharmaceutical (RARE) Holding Value Over Time

Track share changes against reported price movement

Quarterly Ultragenyx Pharmaceutical (RARE) Trades by Ray Dalio

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +57,052 New Buy 57,052 $15.03
Q1 2024 -10,635 Sold Out 0 $0.00
Q4 2023 -754 Reduce 6.62% 10,635 $47.82
Q3 2023 -573 Reduce 4.79% 11,389 $35.65
Q2 2023 -1,706 Reduce 12.48% 11,962 $46.13
Q1 2023 +13,668 New Buy 13,668 $40.10

Ray Dalio's Ultragenyx Pharmaceutical Investment FAQs

Ray Dalio first purchased Ultragenyx Pharmaceutical Inc. (RARE) in Q1 2023, acquiring 13,668 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Ray Dalio has held Ultragenyx Pharmaceutical Inc. (RARE) for 6 quarters since Q1 2023.

Ray Dalio's largest addition to Ultragenyx Pharmaceutical Inc. (RARE) was in Q3 2026, adding 57,052 shares worth $857,492.

According to the latest 13F filing for Q3 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 57,052 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $857,492.

As of the Q3 2026 filing, Ultragenyx Pharmaceutical Inc. (RARE) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.

Ray Dalio's peak holding in Ultragenyx Pharmaceutical Inc. (RARE) was 57,052 shares, as reported at the end of Q3 2026.